| Bioactivity | CTTHWGFTLC, CYCLIC is a cyclic peptide inhibitor for matrix metalloproteinases MMP-2 and MMP-9. The IC50 value for MMP-9 is ~8 μM[1]. |
| Invitro | CTTHWGFTLC, CYCLIC inhibits endothelial and tumor cell migration in vitro[1]. |
| Name | CTTHWGFTLC, CYCLIC |
| CAS | 244082-19-7 |
| Sequence | Cys-Thr-Thr-His-Trp-Gly-Phe-Thr-Leu-Cys (Disulfide Bridge: Cys1-Cys10) |
| Shortening | CTTHWGFTLC (Disulfide Bridge: Cys1-Cys10) |
| Formula | C52H71N13O14S2 |
| Molar Mass | 1166.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
CTTHWGFTLC, CYCLIC
CAS: 244082-19-7 F: C52H71N13O14S2 W: 1166.33
CTTHWGFTLC, CYCLIC is a cyclic peptide inhibitor for matrix metalloproteinases MMP-2 and MMP-9. The IC50 value for MMP-9
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.